Clinical Evidence
254 results
HDx therapy enabled by Theranova
Budget-Impact Analysis of Adopting Expanded Hemodialysis (HDX) Via Theranova® in Korea
HD
C-reactive Protein: Repeated Measurements will Improve Dialysis Patient Care - Cobo et al.
HDx therapy enabled by Theranova
Can better efficacy of middle weight molecules removal in dialysis patients treated with medium cut-off membranes predict superiority over conventional high flux dialysers?
HDx therapy enabled by Theranova
Cardiovascular Risk Comparison between Expanded Hemodialysis Using Theranova and Online Hemodiafiltration (CARTOON): A Multicenter Randomized Controlled Trial.
PD
Case report: Remote monitoring of automated peritoneal dialysis patients: assessing clinical and economic value - Makhija D, et al.
HDx therapy enabled by Theranova
Changes in plasma sclerostin level associated with use of a medium cut-off dialyzer in end-stage renal disease.
HDx therapy enabled by Theranova
Chronic inflammation in end-stage renal disease and dialysis
HDx therapy enabled by Theranova
Citrate anion improves chronic dialysis efficacy, reduces systemic in-flammation and prevents Chemerin-mediated microvascular injury - Dellepiane S et al. Sci Rep 2019
HD
Citrate versus acetate-based dialysate in on-line haemodiafiltration. A prospective cross-over study - Molina NN, et al.
HDx therapy enabled by Theranova
Classification of Uremic Toxins and Their Role in Kidney Failure: An Expert Consensus Conference
Vantive is a trademark of Vantive Health LLC or its affiliates.